Attana has signed a collaborative research agreement with a leading US academic medical center for biomedical research
Attana can today announce that a collaborative research agreement has been signed with one of the leading US academic medical centers for biomedical research.Attana AB has today signed a collaborative research agreement with one of the leading US academic medical centers within biomedical research, focusing on viruses and antibodies. Under the terms of the agreement, Attana will appoint personnel and an Attana Cell[TM] 250 instrument in the United States during Q1. The initial project scope will be performed through mid-June 2022 and can be mutually extended until the end of 2025. The aim